High-dose insulin infusion in patients with COVID-19
BMJ Open Diabetes Res Care
.
2021 Nov;9(2):e002415.
doi: 10.1136/bmjdrc-2021-002415.
Authors
Brandon Del Carpio
1
,
Joseph Trang
2
,
Megan Vallejo
2
,
Michael Nimeh
2
,
Jinjoo Lee
2
,
Kelly Rafferty
3
,
Jordan Messler
4
Affiliations
1
Pharmacy, AdventHealth Orlando, Orlando, Florida, USA
[email protected]
.
2
Pharmacy, AdventHealth East Orlando, Orlando, Florida, USA.
3
Pharmacy, AdventHealth Central Florida, Orlando, Florida, USA.
4
Chief Medical Officer, Glytec, Waltham, Massachusetts, USA.
PMID:
34764139
PMCID:
PMC8587530
DOI:
10.1136/bmjdrc-2021-002415
No abstract available
Keywords:
COVID-19; diabetes mellitus; hyperglycemia; insulin infusion systems; type 2.
Publication types
Letter
MeSH terms
COVID-19*
Humans
Insulin
Insulin Infusion Systems
SARS-CoV-2
Substances
Insulin